Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
232
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

A Case of Multidrug-Resistant Klebsiella pneumoniae Treated with Carrimycin

Wenjun ZhuDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China
,
Yaping TianDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China
,
Lin XiangDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China
,
Linna CaoDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of China
&
Lirong HeDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People’s Republic of ChinaCorrespondence[email protected]
Pages 2365-2369 | Received 03 Feb 2023, Accepted 12 Apr 2023, Published online: 20 Apr 2023

References

  • Stojowska-Swedrzynska K, Lupkowska A, Kuczynska-Wisnik D, Laskowska E. Antibiotic heteroresistance in Klebsiella pneumoniae. Int J Mol Sci. 2022;23(1):449.
  • Tesfa T, Mitiku H, Edae M, Assefa N. Prevalence and incidence of carbapenem-resistant K. pneumoniae colonization: systematic review and meta-analysis. Syst Rev. 2022;11(1). doi:10.1186/s13643-022-02110-3
  • Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther. 2018;16(10):749–761. doi:10.1080/14787210.2018.1522249
  • Galani I, Karaiskos I, Giamarellou H. Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel beta-lactam-beta-lactamase inhibitor combinations. Expert Rev Anti Infect Ther. 2021;19(11):1457–1468. doi:10.1080/14787210.2021.1924674
  • He W, Yang C, Zhao X, Wang Y. Antimicrobial activity of bitespiramycin, a new genetically engineered macrolide. Bioorg Med Chem Lett. 2017;27(19):4576–4577. doi:10.1016/j.bmcl.2017.08.046
  • Wang MJ, Xue J, Zou WB, et al. Identification of the components of bitespiramycin by liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2012;66:402–410. doi:10.1016/j.jpba.2012.03.013
  • Ma C, Zhou H, Li J, et al. Construction of 4-isovalerylspiramycin-I-producing strain by in-frame partial deletion of 3-O-acyltransferase gene in Streptomyces spiramyceticus WSJ-1, the bitespiramycin producer. Curr Microbiol. 2011;62(1):16–20. doi:10.1007/s00284-010-9664-8
  • Shi XG, Sun YM, Zhang YF, Zhong DF. Tissue distribution of bitespiramycin and spiramycin in rats. Acta Pharmacol Sin. 2004;25(11):1396–1401.
  • Wong EHC, Porter JD, Edwards MR, Johnston SL. The role of macrolides in asthma: current evidence and future directions. Lancet Respir Med. 2014;2(8):657–670. doi:10.1016/S2213-2600(14)70107-9
  • Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23(3):590–+. doi:10.1128/CMR.00078-09
  • Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The immunomodulatory effects of macrolides-a systematic review of the underlying mechanisms. Front Immunol. 2018;9. doi:10.3389/fimmu.2018.00302
  • Reijnders TDY, Saris A, Schultz MJ, van der Poll T. Immunomodulation by macrolides: therapeutic potential for critical care. Lancet Respir Med. 2020;8(6):619–630. doi:10.1016/S2213-2600(20)30080-1
  • Pollock J, Chalmers JD. The immunomodulatory effects of macrolide antibiotics in respiratory disease. Pulm Pharmacol Ther. 2021;71:102095.
  • Lin SJ, Kuo ML, Hsiao HS, Lee PT. Azithromycin modulates immune response of human monocyte-derived dendritic cells and CD4(+) T cells. Int Immunopharmacol. 2016;40:318–326. doi:10.1016/j.intimp.2016.09.012
  • Polancec DS, Kos VM, Banjanac M, et al. Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. J Leukoc Biol. 2012;91(2):229–243. doi:10.1189/jlb.1210655
  • Liang SY, Zhao TC, Zhou ZH, et al. Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo. Transl Oncol. 2021;14(6):101074. doi:10.1016/j.tranon.2021.101074
  • Cui J, Zhou JC, He WQ, et al. Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I. J Exp Clin Cancer Res. 2022;41(1). doi:10.1186/s13046-022-02350-0
  • Yan HY, Sun J, Wang K, et al. Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2. Acta Pharmaceutica Sinica B. 2021;11(9):2850–2858. doi:10.1016/j.apsb.2021.02.024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.